FEMY.NASDAQFemasys INC

Form 4: Femasys Inc. Executive Granted Stock Options

Sentiment:

SEC Form 4 Filing


Femasys Inc.'s Chief Operating Officer, Daniel Scott Currie, was granted stock options on January 28, 2025, which vest over three and four years.

Summary

  • Daniel Scott Currie, the Chief Operating Officer of Femasys Inc., was granted stock options on January 28, 2025.
  • These options are for the purchase of Femasys Inc. common stock at an exercise price of $1.05 per share.
  • A total of 229,197 stock options were granted, split into three tranches.
  • The first tranche of 29,184 options vests over three years, while the second tranche of 59,313 and third tranche of 140,700 options vest over four years.
  • Vesting is contingent upon Mr. Currie's continued employment with Femasys or a subsidiary.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management's interests with shareholders. There are no negative implications.

Positives

  • The granting of stock options aligns the executive's interests with those of the shareholders.
  • The vesting schedule encourages long-term commitment from the executive.
  • The exercise price of $1.05 per share provides an incentive for the executive to increase the company's value.

Risks

  • The vesting of the stock options is contingent on continued employment, which could be a risk if the executive leaves the company.
  • The value of the stock options is dependent on the future performance of the company's stock price.

Future Outlook

The stock options will vest over the next three to four years, contingent on the executive's continued employment.

Industry Context

Stock option grants are a common form of executive compensation in the corporate world, particularly in growth-oriented companies like Femasys Inc.

Comparison to Industry Standards

  • Stock option grants are a standard practice for executive compensation across various industries.
  • The vesting period of three to four years is also typical for such grants, aligning with long-term performance goals.
  • The exercise price of $1.05 per share is a common practice, often set at or near the current market price at the time of the grant.

Stakeholder Impact

  • Shareholders may view the stock option grant positively as it incentivizes the executive to improve company performance.
  • Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates

DateDescription
01/28/2025Date of the stock option grant and the start of the vesting period.
01/30/2025Date the form was signed by Kathy Lee-Sepsick, Attorney-in-fact.
01/28/2035Expiration date of the stock options.

Keywords

stock options, executive compensation, Femasys Inc., Daniel Scott Currie, vesting, equity

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.